FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Eugia US Methylprednisolone acetate Injectable Recall

Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Mult…

Eugia US LLC · East Windsor, NJ

Risk level
Class II
Reported by FDA
Mar 13, 2024
Recall ID
D-0366-2024
Check your lot numberHow we source this data

Summary

Eugia US recalled Methylprednisolone acetate Injectable starting Feb 20, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0366-2024 on Mar 13, 2024. Reason: Failed Dissolution Specifications. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications

Product description

Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01

Lot numbers, UPCs & expiration codes

Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025

Where it was sold

OH, TN, LA, MS

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0366-2024
Classification
Class II
Status
Ongoing
Recall initiated
Feb 20, 2024
FDA report date
Mar 13, 2024
Quantity
10,080 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Eugia US LLC

Original FDA data

Every field from FDA enforcement report D-0366-2024, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Ongoing
Country
United States
Event ID
94075
Address
279 Princeton Hightstown Rd
Code information
Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025
Postal code
08520-1401
Report date
Mar 13, 2024
Product type
Drugs
Recall number
D-0366-2024
Classification
Class II
Recalling firm
Eugia US LLC
Product quantity
10,080 vials
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01
Distribution pattern
OH, TN, LA, MS
Recall initiation date
Feb 20, 2024
Initial firm notification
Letter
Center classification date
Mar 4, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0366-2024, published Mar 13, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls